Somatic and germline mutations of the TSH receptor and thyroid diseases

Clinical Endocrinology

Volumn 55, Issue 2, 2001, Pages 143-158

  Corvilain, B ^a,d   Van Sande, J ^b   Dumont, J E ^c   Vassart, G ^a  

^a IRIBHN   (Belgium)

^b Department of Endocrinology ^*  (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; IODINE; THYROTROPIN RECEPTOR;

AGE; AMINO ACID SUBSTITUTION; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; EVOLUTION; FOLLICULAR CARCINOMA; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTHYROIDISM; NODULAR GOITER; NONHUMAN; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SOMATIC MUTATION; STIMULATION; THYROID ADENOMA; THYROID CELL; THYROID HYPERPLASIA;

ANIMALS; CYCLIC AMP; DOGS; GENOTYPE; GERM-LINE MUTATION; HUMANS; HYPERPLASIA; HYPERTHYROIDISM; IODINE; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, THYROTROPIN; STRUCTURE-ACTIVITY RELATIONSHIP; THYROID DISEASES; THYROID GLAND;

EID: 0034822177     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01365.x     Document Type: Review

References (109)

1. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland
2. The spectrum of thyroid disorders in an iodine-deficient community: The Pescopagano survey
3. Genomic DNA analysis of thyrotropin receptor in a family with hereditary hyperthyroidism
4. Substitutions of tyrosine 601 in the human thyrotropin receptor result in increase or loss of basal activation of the cyclic adenosine monophosphate pathway and disrupt coupling to Gq/11
5. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goitre
6. Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism
7. No evidence of thyrotropin receptor and G (s α) gene mutation in high iodine uptake thyroid carcinoma
8. Thyroid function and hyperfunction during gestation
9. A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism
10. Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas
11. Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH
12. Congenital hypothyroidism associated with thyrotropin unresponsiveness and thyroid cell membrane alterations
13. Selenium and the thyroid: How the relationship was established
14. 2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices
15. Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function
16. Decrease of telomere length in thyroid adenomas without telomerase activity
17. Characterization of autonomous thyroid adenoma: Metabolism, gene expression, and pathology
18. Clinical review 84: Thyroid autonomy: Mechanism and clinical effects
19. The cyclic AMP-mediated stimulation of cell proliferation
20. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors
21. Two autonomous nodules of a patient with multinodular goitre harbor different activating mutations of the thyrotropin receptor gene
22. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain
23. Germline mutations in the thyrotropin receptor gene cause non- autoimmune autosomal dominant hyperthyroidism
24. Pathology of the TSH receptor
25. Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase
26. A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis
27. The expanding spectrum of G protein diseases
28. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules
29. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism
30. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goitre
31. Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: Are athyreosis and ectopic thyroid distinct entities?
32. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor
33. The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to pathology
34. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum
35. Novel insights into the molecular mechanisms of human thyrotropin action: Structural, physiological, and therapeutic implications for the glycoprotein hormone family
36. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor
37. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules
38. The autonomously functioning thyroid nodule: Goetsch's disease
39. Structure and function of proteins in G-protein-coupled signal transfer
40. Thyroid diseases: Non toxic diffuse and multinodular goitre
41. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goitres
42. Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene
43. A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family
44. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation
45. Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene
46. Polyclonal and monoclonal thyroid nodules coexist within human multinodular goitres
47. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281 - >isoleucine) in the extracellular domain of the thyrotropin receptor
48. Brief report: Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene
49. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies
50. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient
51. Human chorionic gonadotropin stimulates thyroid hormone secretion, iodide uptake, organification, and adenosine 3′,5′-monophosphate formation in cultured human thyrocytes
52. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations
53. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations
54. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
55. Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid
56. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins
57. The toxic effect of small iodine supplements in patients with autonomous thyroid nodules
58. Two G protein oncogenes in human endocrine tumors
59. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: Structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms
60. Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: Pathologic and molecular studies
61. Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population
62. The thyrotropin receptor 25 years after its discovery: New insight after its molecular cloning
63. Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling
64. Activating point mutations of the gsp oncogene in human thyroid adenomas
65. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas
66. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
67. 2+ cascades
68. Molecular cloning of the thyrotropin receptor
69. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid
70. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy
71. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas
72. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy
73. Constitutively active mutants of the alpha 2-adrenergic receptor
74. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin
75. Four families with loss of function mutations of the thyrotropin receptor
76. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism
77. Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease
78. Activating mutations of the TSH receptor in differentiated thyroid carcinomas
79. Genetic alterations in thyroid hyperfunctioning adenomas
80. A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH
81. A Val 677 activating mutation of the thyrotropin receptor in a Hurthle cell thyroid carcinoma associated with thyrotoxicosis
82. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model
83. Long-term follow-up in patients with autonomous thyroid adenoma
84. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty
85. The natural history of the autonomous hyperfunctioning thyroid nodule
86. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: Low prevalence of mutations predicts infrequent involvement in malignant transformation
87. Congenital hypothyroidism with impaired thyroid response to thyrotropin
88. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse
89. Brief report: Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene
90. Thyroid function in hyperemesis gravidarum
91. The detection of somatic mutations of thyrotropin receptor gene in fine needle biopsy samples from thyroid nodules
92. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan
93. Screening of thyrotropin receptor mutations by fine-needle aspiration biopsy in autonomous functioning thyroid nodules in multinodular goitres
94. Familial hyperthyroidism without evidence of autoimmunity
95. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype
96. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goitre
97. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: Evidence for a new inactivating mutation of the TSH receptor gene
98. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene
99. Hyperfunctioning thyroid nodules in toxic multinodular goitre share activating thyrotropin receptor mutations with solitary toxic adenoma
100. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia
101. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms
102. Pathogenesis of autonomous thyroid nodules: In vitro study of iodine and adenosine 3′,5′-monophosphate metabolism
103. Specific activation of the thyrotropin receptor by trypsin
104. Somatic and germline mutations of the TSH receptor gene in thyroid diseases
105. In Chinese hamster ovary K1 cells dog and human thyrotropin receptors activate both the cyclic AMP and the phosphatidylinositol 4,5-bisphosphate cascades in the presence of thyrotropin and the cyclic AMP cascade in its absence
106. The thyrotropin receptor and the regulation of thyrocyte function and growth
107. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome
108. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization
109. Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation